94 related articles for article (PubMed ID: 10347749)
1. Main features of DNA-based immunization vectors.
Azevedo V; Levitus G; Miyoshi A; Cândido AL; Goes AM; Oliveira SC
Braz J Med Biol Res; 1999 Feb; 32(2):147-53. PubMed ID: 10347749
[TBL] [Abstract][Full Text] [Related]
2. The antibiotic resistance-free mammalian expression plasmid vector pPAL for development of third generation vaccines.
Alcolea PJ; Alonso A; Larraga V
Plasmid; 2019 Jan; 101():35-42. PubMed ID: 30529129
[TBL] [Abstract][Full Text] [Related]
3. A family of compact plasmid vectors for DNA immunization in humans.
Herrera AM; Rodríguez EG; Hernández T; Sández B; Duarte CA
Biochem Biophys Res Commun; 2000 Dec; 279(2):548-51. PubMed ID: 11118323
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of DNA vaccine-induced immune responses by a 72-bp element from SV40 enhancer.
Li HS; Liu Y; Li DF; Zhang RR; Tang HL; Zhang YW; Huang W; Liu Y; Peng H; Xu JQ; Hong KX; Shao YM
Chin Med J (Engl); 2007 Mar; 120(6):496-502. PubMed ID: 17439744
[TBL] [Abstract][Full Text] [Related]
5. Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines.
Verch T; Pan ZK; Paterson Y
Infect Immun; 2004 Nov; 72(11):6418-25. PubMed ID: 15501772
[TBL] [Abstract][Full Text] [Related]
6. An improved plasmid DNA expression vector for direct injection into skeletal muscle.
Hartikka J; Sawdey M; Cornefert-Jensen F; Margalith M; Barnhart K; Nolasco M; Vahlsing HL; Meek J; Marquet M; Hobart P; Norman J; Manthorpe M
Hum Gene Ther; 1996 Jun; 7(10):1205-17. PubMed ID: 8793545
[TBL] [Abstract][Full Text] [Related]
7. Optimization of plasmid vectors for high-level expression in lung epithelial cells.
Yew NS; Wysokenski DM; Wang KX; Ziegler RJ; Marshall J; McNeilly D; Cherry M; Osburn W; Cheng SH
Hum Gene Ther; 1997 Mar; 8(5):575-84. PubMed ID: 9095409
[TBL] [Abstract][Full Text] [Related]
8. Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system.
Luke J; Carnes AE; Hodgson CP; Williams JA
Vaccine; 2009 Oct; 27(46):6454-9. PubMed ID: 19559109
[TBL] [Abstract][Full Text] [Related]
9. Development of improved vectors for DNA-based immunization and other gene therapy applications.
Norman JA; Hobart P; Manthorpe M; Felgner P; Wheeler C
Vaccine; 1997 Jun; 15(8):801-3. PubMed ID: 9234518
[TBL] [Abstract][Full Text] [Related]
10. A series of yeast/Escherichia coli lambda expression vectors designed for directional cloning of cDNAs and cre/lox-mediated plasmid excision.
Brunelli JP; Pall ML
Yeast; 1993 Dec; 9(12):1309-18. PubMed ID: 8154182
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
Jiang H; Hu Y; Yang M; Liu H; Jiang G
Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
[TBL] [Abstract][Full Text] [Related]
12. Regulation of transgene expression in genetic immunization.
Harms JS; Oliveira SC; Splitter GA
Braz J Med Biol Res; 1999 Feb; 32(2):155-62. PubMed ID: 10347750
[TBL] [Abstract][Full Text] [Related]
13. Aberrant cryptic responsiveness of the pCAT 3- and pGL3-promoter reporter vectors.
Giannakis G; Edmondson SR; Favaloro JM; Zajac JD; Greenland KJ
Biotechniques; 2003 Aug; 35(2):332-9. PubMed ID: 12951775
[TBL] [Abstract][Full Text] [Related]
14. The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens.
Schirmbeck R; Reimann J; Kochanek S; Kreppel F
Mol Ther; 2008 Sep; 16(9):1609-16. PubMed ID: 18612271
[TBL] [Abstract][Full Text] [Related]
15. The 35S promoter used in a selectable marker gene of a plant transformation vector affects the expression of the transgene.
Yoo SY; Bomblies K; Yoo SK; Yang JW; Choi MS; Lee JS; Weigel D; Ahn JH
Planta; 2005 Jun; 221(4):523-30. PubMed ID: 15682278
[TBL] [Abstract][Full Text] [Related]
16. Protection against leptospirosis by immunization with plasmid DNA encoding 33 kDa endoflagellin of L. interrogans serovar lai.
Dai B; You Z; Chen Z; Yan H; Fang Z
Chin Med Sci J; 2000 Mar; 15(1):14-9. PubMed ID: 12899392
[TBL] [Abstract][Full Text] [Related]
17. Plasmid DNA production for therapeutic applications.
Lara AR; Ramírez OT; Wunderlich M
Methods Mol Biol; 2012; 824():271-303. PubMed ID: 22160904
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid immunization: concepts and techniques associated with third generation vaccines.
Hasan UA; Abai AM; Harper DR; Wren BW; Morrow WJ
J Immunol Methods; 1999 Oct; 229(1-2):1-22. PubMed ID: 10556687
[TBL] [Abstract][Full Text] [Related]
19. A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates.
Barouch DH; Yang ZY; Kong WP; Korioth-Schmitz B; Sumida SM; Truitt DM; Kishko MG; Arthur JC; Miura A; Mascola JR; Letvin NL; Nabel GJ
J Virol; 2005 Jul; 79(14):8828-34. PubMed ID: 15994776
[TBL] [Abstract][Full Text] [Related]
20. The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines.
Garg S; Oran AE; Hon H; Jacob J
J Immunol; 2004 Jul; 173(1):550-8. PubMed ID: 15210816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
